Document Detail

Stereotactic Radiosurgery for Recurrent or Unresectable Pilocytic Astrocytoma.
MedLine Citation:
PMID:  22019245     Owner:  NLM     Status:  Publisher    
PURPOSE: To report the outcomes in patients with recurrent or unresectable pilocytic astrocytoma (PA) treated with Gamma Knife stereotactic radiosurgery (SRS). METHODS AND MATERIALS: Retrospective review of 18 patients (20 lesions) with biopsy-confirmed PA having SRS at our institution from 1992 through 2005. RESULTS: The median patient age at SRS was 23 years (range, 4-56). Thirteen patients (72%) had undergone one or more previous surgical resections, and 10 (56%) had previously received external-beam radiation therapy (EBRT). The median SRS treatment volume was 9.1 cm(3) (range, 0.7-26.7). The median tumor margin dose was 15 Gy (range, 12-20). The median follow-up was 8.0 years (range, 0.5-15). Overall survival at 1, 5, and 10 years after SRS was 94%, 71%, and 71%, respectively. Tumor progression (local solid progression, n = 4; local solid progression + distant, n = 1; distant, n = 2; cyst development/progression, n = 4) was noted in 11 patients (61%). Progression-free survival at 1, 5, and 10 years was 65%, 41%, and 17%, respectively. Prior EBRT was associated with inferior overall survival (5-year risk, 100% vs. 50%, p = 0.03) and progression-free survival (5-year risk, 71% vs. 20%, p = 0.008). Nine of 11 patients with tumor-related symptoms improved after SRS. Symptomatic edema after SRS occurred in 8 patients (44%), which resolved with short-term corticosteroid therapy in the majority of those without early disease progression. CONCLUSIONS: SRS has low permanent radiation-related morbidity and durable local tumor control, making it a meaningful treatment option for patients with recurrent or unresectable PA in whom surgery and/or EBRT has failed.
Christopher L Hallemeier; Bruce E Pollock; Paula J Schomberg; Michael J Link; Paul D Brown; Scott L Stafford
Related Documents :
19486255 - Combination therapy with transarterial chemoembolization and interferon-alpha compared ...
11022825 - Outcomes of primary hepatocellular carcinoma treatment: an 8-year experience with 368 p...
11930055 - Ct-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not...
9736905 - Staged hepatectomy after emergency transcatheter arterial embolization for ruptured hep...
7058825 - The decision between single- and combined-modality therapy in hodgkin's disease.
10617245 - An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-20
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  -     ISSN:  1879-355X     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Department of Radiation Oncology, Mayo Clinic, Rochester, MN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Day-to-Day Reproducibility of Prostate Intrafraction Motion Assessed by Multiple kV and MV Imaging o...
Next Document:  Treatment Trends and Outcomes of Small-Cell Carcinoma of the Bladder.